GlassScriptPhysician profile
Amanda Cantor
NPI 1972967586
$1,619.74
in general payments reported to CMS, 2019-2025
5 companies · $766 in 2025
The $766 reported for 2025 was more than what a typical Pediatric Transplant Hepatology provider received nationally (typical 2025 total: $425).
See the full distribution for Pediatric Transplant Hepatology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $64.68 · 2023: $97.88 · 2024: $691 · 2025: $766.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,555.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $892.05 | 2024-2025 | Bylvay |
| Mirum Pharmaceuticals, INC. | $533.60 | 2022-2025 | Livmarli, Chenodal, Cholbam |
| Madrigal Pharmaceuticals | $98.22 | 2025 | Rezdiffra |
| Orphalan INC | $95.87 | 2024-2025 | Cuvrior |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Cantor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.